PARNELL PHARMACEUT HLDGS LTD's ticker is PARNF and the CUSIP is Q73622104. A total of 18 filers reported holding PARNELL PHARMACEUT HLDGS LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 400 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | -50.0% | 400 | -50.0% | 0.00% | 0.0% |
| Q1 2016 | $2,000 | -33.3% | 800 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $3,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 448,802 | $637,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 369,700 | $532,000 | 0.02% |
| ATWOOD & PALMER INC | 16,900 | $24,000 | 0.00% |
| Alyeska Investment Group, L.P. | 147,458 | $209,000 | 0.00% |
| AlphaMark Advisors, LLC | 400 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 562,896 | $799,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 24,300 | $35,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,000 | $14,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 690 | $1,000 | 0.00% |
| Creative Planning | 5,500 | $8,000 | 0.00% |